Display Options:
Total: 1404
Antibody
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell
Leukocyte antigen CD37 binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Lymphoma
CD22 binding agent
Antibody
Investigational
Unknown
Unknown
Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms
Proheparin-binding EGF-like growth factor inhibitor
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Interleukin-3 receptor subunit alpha inhibitor
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
Antibody
Investigational
Unknown
Unknown
Multiple Myeloma; Hematologic Neoplasms
G-protein coupled receptor family C group 5 member D binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Mucin-1 binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Ovarian Neoplasms
Epithelial cell adhesion molecule other
Antibody
Investigational
Unknown
Unknown
Neoplasms
Teratocarcinoma-derived growth factor 1 binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Mucin-1 other
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Squamous Cell; Histiocytoma, Malignant Fibrous
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Tyrosine-protein kinase receptor FLT3 inhibitor
Antibody
Investigational
Unknown
Unknown
Anthrax; Hypersensitivity
Protective antigen inhibitor
Antibody
Unknown
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Glycoprotein inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Severe Combined Immunodeficiency
Stem cell growth factor receptor inhibitor
Antibody
Investigational
Unknown
Unknown
Dermatitis, Atopic; Rhinitis, Allergic, Seasonal
Ig epsilon chain C region inhibitor
Antibody
Investigational
Unknown
Unknown
Melanoma
5,6-dihydroxyindole-2-carboxylic acid oxidase other
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Bone Diseases, Metabolic
Sclerostin inhibitor
Antibody
Investigational
Unknown
Unknown
Colorectal Neoplasms
Cell surface A33 antigen binding agent
Antibody
Investigational
Unknown
Unknown
Prostatic Neoplasms
Glutamate carboxypeptidase II binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Adenocarcinoma
Carcinoembryonic antigen-related cell adhesion molecule 5 cross-linking agent
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms; Pancreatic Neoplasms
Frizzled-1 antagonist